Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Jay Lin, Melissa Lingohr-Smith & Tao Fan. (2017) Real-world medication persistence and outcomes associated with basal insulin and glucagon-like peptide 1 receptor agonist free-dose combination therapy in patients with type 2 diabetes in the US. ClinicoEconomics and Outcomes Research 9, pages 19-29.
Read now
Read now
P. Chevalier, T. Vandebrouck, D. De Keyzer, A. Mertens & M. Lamotte. (2016) Cost and co-morbidities associated with hypoglycemic inpatients in Belgium. Journal of Medical Economics 19:1, pages 44-52.
Read now
Read now
Meryl Brod, Michael Wolden, Danielle Groleau & Donald M. Bushnell. (2014) Understanding the economic, daily functioning, and diabetes management burden of non-severe nocturnal hypoglycemic events in Canada: differences between type 1 and type 2. Journal of Medical Economics 17:1, pages 11-20.
Read now
Read now
Stewart B Harris, Kamlesh Khunti, Mona Landin-Olsson, Claus B Galbo-Jørgensen, Mette Bøgelund, Barrie Chubb, Jens Gundgaard & Marc Evans. (2013) Descriptions of health states associated with increasing severity and frequency of hypoglycemia: a patient-level perspective. Patient Preference and Adherence 7, pages 925-936.
Read now
Read now
A.H. Barnett, R. Brice, W. Hanif, J. James & H. Langerman. (2013) Increasing awareness of hypoglycaemia in patients with Type 2 diabetes treated with oral agents. Current Medical Research and Opinion 29:11, pages 1503-1513.
Read now
Read now
Meryl Brod, Azhar Rana & Anthony H. Barnett. (2012) Adherence patterns in patients with type 2 diabetes on basal insulin analogues: missed, mistimed and reduced doses. Current Medical Research and Opinion 28:12, pages 1933-1946.
Read now
Read now
Articles from other publishers (39)
Julie Maria Bøggild Brøsen, Rikke Mette Agesen, Amra Ciric AlibegovicHenrik Ullits AndersenHenning Beck-NielsenPeter GustenhoffTroels Krarup HansenChristoffer Georg Riber HedetoftTonny Joran JensenCharlotte Røn StolbergClaus Bogh JuhlSusanne Søgaard LercheKirsten NørgaardHans-Henrik ParvingLise TarnowBirger ThorsteinssonUlrik Pedersen-Bjergaard. (2022) Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia. Diabetes Technology & Therapeutics 24:9, pages 643-654.
Crossref
Crossref
Yixiang Deng, Lu Lu, Laura Aponte, Angeliki M. Angelidi, Vera Novak, George Em Karniadakis & Christos S. Mantzoros. (2021) Deep transfer learning and data augmentation improve glucose levels prediction in type 2 diabetes patients. npj Digital Medicine 4:1.
Crossref
Crossref
Alexander Turchin & Luisa F. Florez Builes. (2021) Using Natural Language Processing to Measure and Improve Quality of Diabetes Care: A Systematic Review. Journal of Diabetes Science and Technology 15:3, pages 553-560.
Crossref
Crossref
Wael A. Alanazi. (2020) Role of Carnitine on Hematological Parameters and Attenuation of Cardiac (Pro)renin Receptor and Caspase-3 Expression in Hypoglycemia-induced Cardiac Hypertrophy. International Journal of Pharmacology 16:3, pages 191-200.
Crossref
Crossref
Jeremy H. Pettus, Fang Liz Zhou, Leah Shepherd, Katie Mercaldi, Ronald Preblick, Phillip R. Hunt, Sachin Paranjape, Kellee M. Miller & Steven V. Edelman. (2019) Differences between patients with type 1 diabetes with optimal and suboptimal glycaemic control: A real‐world study of more than 30 000 patients in a US electronic health record database. Diabetes, Obesity and Metabolism 22:4, pages 622-630.
Crossref
Crossref
Ulrik Pedersen‐Bjergaard, Saud Alsifri, Ronnie Aronson, Maja Cigrovski Berković, Gagik Galstyan, Helge Gydesen, Jesper Barner Lekdorf, Bernhard Ludvik, Erik Moberg, Ambady Ramachandran & Kamlesh Khunti. (2019) Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real‐world studies. Diabetes, Obesity and Metabolism 21:4, pages 844-853.
Crossref
Crossref
Tanja Pate, Simona Klemenčič, Tadej Battelino & Nataša Bratina. (2016) Fear of hypoglycemia, anxiety, and subjective well-being in parents of children and adolescents with type 1 diabetes. Journal of Health Psychology 24:2, pages 209-218.
Crossref
Crossref
Rodrigo Nunes Lamounier, Bruno Geloneze, Silmara Oliveira Leite, Renan MontenegroJr.Jr., Lenita Zajdenverg, Milene Fernandes, Fabiano de Oliveira Griciunas, Mariana Narbot Ermetice & António Roberto Chacra. (2018) Hypoglycemia incidence and awareness among insulin-treated patients with diabetes: the HAT study in Brazil. Diabetology & Metabolic Syndrome 10:1.
Crossref
Crossref
Pranay Goel, Durga Parkhi, Amlan Barua, Mita Shah & Saroj Ghaskadbi. (2018) A Minimal Model Approach for Analyzing Continuous Glucose Monitoring in Type 2 Diabetes. Frontiers in Physiology 9.
Crossref
Crossref
Marjorie R. Ortiz. (2017) Hypoglycemia in Diabetes. Nursing Clinics of North America 52:4, pages 565-574.
Crossref
Crossref
Freddy Goldberg Eliaschewitz & Tânia Barreto. (2016) Concepts and clinical use of ultra-long basal insulin. Diabetology & Metabolic Syndrome 8:1.
Crossref
Crossref
Anthony P. Nunes, Jing Yang, Larry Radican, Samuel S. Engel, Karen Kurtyka, Kaan Tunceli, Shengsheng Yu, Kristy Iglay, Michael C. Doherty & David D. Dore. (2016) Assessing occurrence of hypoglycemia and its severity from electronic health records of patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 121, pages 192-203.
Crossref
Crossref
Shi-Wei Yang, Kyoung-Ha Park & Yu-Jie Zhou. (2016) The Impact of Hypoglycemia on the Cardiovascular System. Angiology 67:9, pages 802-809.
Crossref
Crossref
Pavika J Lyngsie, Sandra Lopes & Jens Olsen. (2016) Incidence and cost of hypoglycemic events requiring medical assistance in a hospital setting in Denmark. Journal of Comparative Effectiveness Research 5:3, pages 239-247.
Crossref
Crossref
Gyuri Kim, Yong-ho Lee, Mi Hye Han, Eui-Kyung Lee, Chong Hwa Kim, Hyuk Sang Kwon, In Kyung Jeong, Eun Seok Kang & Dae Jung Kim. (2016) Economic Burden of Hypoglycemia in Patients with Type 2 Diabetes Mellitus from Korea. PLOS ONE 11:3, pages e0151282.
Crossref
Crossref
Wendy Klein-Schwartz, Gina L. Stassinos & Geoffrey K. Isbister. (2016) Treatment of sulfonylurea and insulin overdose. British Journal of Clinical Pharmacology 81:3, pages 496-504.
Crossref
Crossref
Lisa Elliott, Carrie Fidler, Andrea Ditchfield & Trine Stissing. (2016) Hypoglycemia Event Rates: A Comparison Between Real-World Data and Randomized Controlled Trial Populations in Insulin-Treated Diabetes. Diabetes Therapy 7:1, pages 45-60.
Crossref
Crossref
Dimitrios Baltzis, Maria G. Grammatikopoulou, Nikolaos Papanas, Christina-Maria Trakatelli, Evangelia Kintiraki, Maria N. Hassapidou & Christos Manes. (2016) Obese Patients with Type 2 Diabetes on Conventional Versus Intensive Insulin Therapy: Efficacy of Low-Calorie Dietary Intervention. Advances in Therapy 33:3, pages 447-459.
Crossref
Crossref
Nanette C. Schloot, Axel Haupt, Morten Schütt, Klaus Badenhoop, Markus Laimer, Claudia Nicolay, Matthew Reaney, Katharina Fink & Reinhard W. Holl. (2016) Risk of severe hypoglycemia in sulfonylurea-treated patients from diabetes centers in Germany/Austria: How big is the problem? Which patients are at risk?. Diabetes/Metabolism Research and Reviews 32:3, pages 316-324.
Crossref
Crossref
Diethelm Tschöpe, Peter Bramlage, Steffen Schneider & Anselm K Gitt. (2015) Incidence, characteristics and impact of hypoglycaemia in patients receiving intensified treatment for inadequately controlled type 2 diabetes mellitus. Diabetes and Vascular Disease Research 13:1, pages 2-12.
Crossref
Crossref
Katie Baker. (2016) Comparison of bioartificial and artificial pancreatic transplantation as promising therapies for Type I Diabetes Mellitus. Bioscience Horizons 9, pages hzw002.
Crossref
Crossref
Meryl Brod, Lise Højbjerre, Donald M. Bushnell & Charlotte Thim Hansen. (2015) Assessing the impact of non-severe hypoglycemic events and treatment in adults: development of the Treatment-Related Impact Measure—Non-severe Hypoglycemic Events (TRIM-HYPO). Quality of Life Research 24:12, pages 2971-2984.
Crossref
Crossref
Marina Vladimirovna Shestakova, Michail Vladimirovich Antciferov, Alexander Yur'evich Mayorov, Luydmila Alexandrovna Ruyatkina, Ludmila Alexandrovna Suplotova, Sergey Anatol'evich Dogadin, Nikolay Borisovich Lebedev & Yana Gennadievna Alekseeva. (2015) Insulin degludec: a new basal insulin analogue with an ultra-long duration of action. Safety and efficacy in Russian patients with diabetes. Diabetes mellitus 18:4, pages 130-141.
Crossref
Crossref
Emmanuel D. Williams, Steven C. Rogers, Xiaomin Zhang, Gohar Azhar & Jeanne Y. Wei. (2015) Elevated oxygen consumption rate in response to acute low-glucose stress: Metformin restores rate to normal level. Experimental Gerontology 70, pages 157-162.
Crossref
Crossref
Lukas SchauppKlaus DonsaKatharina M. NeubauerJulia K. MaderFelix AbererBernhard HöllStephan SpatThomas AugustinPeter BeckThomas R. PieberJohannes Plank. (2015) Taking a Closer Look—Continuous Glucose Monitoring in Non-Critically Ill Hospitalized Patients with Type 2 Diabetes Mellitus Under Basal-Bolus Insulin Therapy. Diabetes Technology & Therapeutics 17:9, pages 611-618.
Crossref
Crossref
Julia A. Carlson, Kay Craven & Kathryn Kolasa. (2015) Feeding Insulin. Nutrition Today 50:3, pages 109-116.
Crossref
Crossref
Martin M. Grajower. (2015) Adding Rapid-Acting Insulin or Glp-1 Receptor Agonist to Basal Insulin: Penny Wise and Pound Foolish?. Endocrine Practice 21:1, pages 88-90.
Crossref
Crossref
C. S. Wendel, G. G. Fotieo, J. H. Shah, J. Felicetta, B. H. Curtis & G. H. Murata. (2014) Incidence of non-severe hypoglycaemia and intensity of treatment among veterans with Type 2 diabetes in the USA: a prospective observational study. Diabetic Medicine 31:12, pages 1524-1531.
Crossref
Crossref
Peter N. Weissman, Molly C. Carr, June Ye, Deborah T. Cirkel, Murray Stewart, Caroline Perry & Richard Pratley. (2014) HARMONY 4: randomised clinical trial comparing once-weekly albiglutide and insulin glargine in patients with type 2 diabetes inadequately controlled with metformin with or without sulfonylurea. Diabetologia 57:12, pages 2475-2484.
Crossref
Crossref
N. Munro & A. H. Barnett. (2014) Incidence, worry and discussion about dosing irregularities and self-treated hypoglycaemia amongst HCPs and patients with type 2 diabetes: results from the UK cohort of the Global Attitudes of Patient and Physicians (GAPP2) survey. International Journal of Clinical Practice 68:6, pages 692-699.
Crossref
Crossref
Jerry D. MeeceTeresa L. PearsonLinda M. Siminerio. (2014) Complementary Approaches to Improving Glucose Control—Insulin and Incretins. The Diabetes Educator 40:1_suppl, pages 4S-26S.
Crossref
Crossref
Meryl Brod, Michael Wolden, Torsten Christensen & Donald M. Bushnell. (2013) Understanding the Economic Burden of Nonsevere Nocturnal Hypoglycemic Events: Impact on Work Productivity, Disease Management, and Resource Utilization. Value in Health 16:8, pages 1140-1149.
Crossref
Crossref
Jeff Unger. (2013) Educating Patients About Hypoglycemia Prevention and Self-Management. Clinical Diabetes 31:4, pages 179-188.
Crossref
Crossref
Stephen C.L. GoughAnuj Bhargava, Rajeev Jain, Henriette Mersebach, Søren Rasmussen & Richard M. Bergenstal. (2013) Low-Volume Insulin Degludec 200 Units/mL Once Daily Improves Glycemic Control Similarly to Insulin Glargine With a Low Risk of Hypoglycemia in Insulin-Naïve Patients With Type 2 Diabetes. Diabetes Care 36:9, pages 2536-2542.
Crossref
Crossref
M. Brod, M. Wolden, T. Christensen & D. M. Bushnell. (2013) A nine country study of the burden of non‐severe nocturnal hypoglycaemic events on diabetes management and daily function. Diabetes, Obesity and Metabolism 15:6, pages 546-557.
Crossref
Crossref
R.-P. Radermecker, C. Fayolle, J.-F. Brun, J. Bringer & E. Renard. (2013) Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion. Diabetes & Metabolism 39:3, pages 258-262.
Crossref
Crossref
Sean Surman & Linda Fleeman. (2013) Continuous Glucose Monitoring in Small Animals. Veterinary Clinics of North America: Small Animal Practice 43:2, pages 381-406.
Crossref
Crossref
Srikanth Bellary, Hillary Cameron, Kirsty Macleod, Michael Malecha, Krisna Koria, Praveen Raja, Jesús Diago Cabezudo & John Ellison. (2012) Clinical evaluation of a novel test strip technology for blood glucose monitoring: Accuracy at hypoglycaemic glucose levels. Diabetes Research and Clinical Practice 98:3, pages 430-435.
Crossref
Crossref
Padhraig Ryan. (2012) Paying for Performance. International Journal of Public and Private Healthcare Management and Economics 2:2, pages 1-16.
Crossref
Crossref